Join to View Full Profile
9500 Gilman DriveLa Jolla, CA 92093
Dr. feldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Certifications & Licensure
CA State Medical License 2016 - 2026
Publications & Presentations
PubMed
- Effects of exercise versus usual care on older adults with amnestic mild cognitive impairment: EXERT versus ADNI.Aladdin H Shadyab, Vahan Aslanyan, Diane M Jacobs, David P Salmon, Rosemary Morrison
Alzheimer's & Dementia. 2025-04-01 - Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study.Laura D Baker, Judy A Pa, Jeffrey A Katula, Vahan Aslanyan, David P Salmon
Alzheimer's & Dementia. 2025-04-01 - Brain health PRO/Santé cerveau PRO: The development of a web-based program for dementia literacy and risk factor reduction.Sylvie Belleville, Nicole D Anderson, Louis Bherer, Richard Camicioli, Julie Carrier
The Journal of Prevention of Alzheimer's Disease. 2025-03-15
Press Mentions
Even Light Exercise Could Help Slow Cognitive Decline in People at Risk of Alzheimer's DiseaseApril 24th, 2025- Even Light Exercise Could Help Slow Cognitive Decline in People at Risk of Alzheimer'sApril 24th, 2025
- Light Exercise May Slow Cognitive Decline in Individuals at Risk for Alzheimer’s, Study FindsApril 24th, 2025
Grant Support
- Phase II randomized controlled trial of benfotiamine in early Alzheimer's DiseaseWINIFRED MASTERSON BURKE MED RES INST2022–2028
- A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2019–2025
- A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
